placeholder newsslider


ARVO2020 cancelled because of Coronavirus (COVID-19)

ARVO has decided to cancel the Annual Meeting to have taken place May 1 – 7 in Baltimore, Md, USA

New Technologies for Outcome Measures in Uveal Melanoma

Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology

Biden pursues giant boost for science spending

US president’s first budget proposal emphasizes applied research and public health, and aims to tackle climate change and racial injustice.

Essilor to Present New Results for its Stellest Lens for Children With Myopia

Essilor will unveil pivotal 2-year clinical trial results of its Stellest lens for myopia. The 2-year results demonstrate that Essilor Stellest lenses slow down myopia progression by 67% on average, when compared to single vision lenses, when worn at least 12 hours a day, according to Essilor.

‘We must adapt’: EU research chief on Europe’s €100-billion funding programme

Commissioner Mariya Gabriel will oversee the implementation of the Horizon Europe scheme.

Publication of Preclinical Efficacy Results on IOP-Lowering Compounds announced

Nicox SA anounces the publication of Preclinical Efficacy Results on a new class of Non-PGA NO-Donating IOP-Lowering Compounds

Bausch + Lomb Launches Alaway Preservative Free Antihistamine Eye Drops

Bausch + Lomb announced the US launch of Alaway Preservative Free (ketotifen fumarate ophthalmic solution 0.035%) antihistamine eye drops. Bausch + Lomb says Alaway is the first and only over-the-counter (OTC) preservative-free antihistamine eye itch relief drop approved by the FDA.

Treating vision loss globally would have social and economic benefits

Written by 73 leading experts from 25 countries, The Lancet Global Health Commission Report on Global Eye Health reveals that with the right tools, strategies, and sufficient funding, improving eye health can have immediate and substantial benefits for the economic and social prosperity of individuals and nations.

VRmagic Eyesi Slit Lamp Fundoscopy Module Launched in the UK

VRmagic’s new Fundoscopy Module can be mounted to the Eyesi Slit Lamp simulator table to enable a lifelike interaction. It is supported by comprehensive software offering a wide selection of cases for retinal examination, which will be continuously extended, according to a company news release.

How Europe's €100 billion science fund will shape 7 years of research

Horizon Europe, the world’s largest multinational research and innovation programme, has issued its first call for grant applications.

Prof Andrew Dick reappointed as Director of IoO

Congratulations to Professor Andrew Dick for being reappointed as Director of UCL Institute of Ophthalmology for the next five years.

Aerie Pharmaceuticals Receives European Commission Approval for Glaucoma Treatment Roclanda

Aerie Pharmaceuticals announced the European Commission (EC) has granted a marketing authorization for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction of elevated IOP in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.

Beacon Bursaries awarded to IoO and Slade School of Fine Art joint project

IoO's Dr Emily Patterson and UCL Slade School of Fine Art's Jo Guile were selected in the latest round of the Beacon Bursary public engagement funding scheme.

International Council of Ophthalmology supports WHO’s guide on DR screening

The International Council of Ophthalmology participated in the launch of a diabetic retinopathy screening guide developed by the WHO Regional Office for Europe.

Tamara Fountain begins Term as 2021 President of the American Academy of Ophthalmology

The university professor will focus on pandemic recovery, supporting diversity in medicine